Failure of SGLT-2 inhibitor in the context of new ileal conduit formation

被引：0
|
作者：
Almog, Joel [1 ,4 ]
Jain, Shalu [2 ]
Pybass, Phillip [3 ]
Gupta, Ankur [1 ]
机构：
[1] Te Whatu Ora Hlth New Zealand Midcent Dist, Dept Nephrol, Hamilton, New Zealand
[2] Te Whatu Ora Hlth New Zealand Midcent Dist, Diabet & Endocrinol Serv, Hamilton, New Zealand
[3] Te Whatu Ora Hlth New Zealand Midcent Dist, Dept Internal Med, Hamilton, New Zealand
[4] Palmerston North Hosp, Ground Floor,50 Ruahine St, Palmerston North 4442, New Zealand
来源：
NEW ZEALAND MEDICAL JOURNAL | 2023年 / 136卷 / 1571期
关键词：
D O I：
暂无
中图分类号：
R5 [内科学];
学科分类号：
1002 ; 100201 ;
摘要：
引用
收藏
页码：83 / 85
页数：3
相关论文
共 50 条
  • [41] Effects of the SGLT-2 inhibitor dapagliflozin on glomerular and tubular injury markers
    Dekkers, Claire C. J.
    Petrykiv, Sergei
    Laverman, Gozewijn D.
    Cherney, David Z.
    Gansevoort, Ron T.
    Heerspink, Hiddo J. L.
    DIABETES OBESITY & METABOLISM, 2018, 20 (08): : 1988 - 1993
  • [42] ROBUSTNESS OF OUTCOMES IN SGLT-2 INHIBITOR TRIALS IN PATIENTS WITH HEART FAILURE WITH MILDLY REDUCED OR PRESERVED EJECTION FRACTION
    Ariss, Robert
    Dimitri, Demetrio Sharp
    Levy, Wayne C.
    Pourriahi, Mahyar
    JOURNAL OF THE AMERICAN COLLEGE OF CARDIOLOGY, 2023, 81 (08) : 758 - 758
  • [43] Q: Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease?
    Sekerak, Richard
    Lerner, Johanna Ben-Ami
    Prasad, Pooja
    Prasad, Megha
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2023, 90 (10) : 607 - 609
  • [44] Should I start an SGLT-2 inhibitor in my patient with heart failure and chronic kidney disease? Reply
    Prasad, Pooja
    Prasad, Megha
    CLEVELAND CLINIC JOURNAL OF MEDICINE, 2024, 91 (02) : 82 - 83
  • [45] SGLT-2 Inhibitor Use and Cause-Specific Hospitalization Rates: An Outcome-Wide Study to Identify Novel Associations of SGLT-2 Inhibitors
    Tan, George S. Q.
    Morton, Jedidiah I.
    Wood, Stephen
    Shaw, Jonathan E.
    Magliano, Dianna J.
    Ilomaki, Jenni
    CLINICAL PHARMACOLOGY & THERAPEUTICS, 2024, 115 (06) : 1304 - 1315
  • [46] How Do SGLT-2 Inhibitors Work to Prevent Heart Failure?
    Vaduganathan, Muthiah
    Claggett, Brian L.
    Solomon, Scott D.
    JACC-HEART FAILURE, 2020, 8 (01) : 67 - 69
  • [47] SGLT-2 Inhibitors in Heart Failure: Guide for Prescribing and Future Perspectives
    Garla, Vishnu Vardhan
    Butler, Javed
    Lien, Lillian F.
    CURRENT CARDIOLOGY REPORTS, 2021, 23 (06)
  • [48] SGLT-2 Inhibitors in Heart Failure: Guide for Prescribing and Future Perspectives
    Vishnu Vardhan Garla
    Javed Butler
    Lillian F. Lien
    Current Cardiology Reports, 2021, 23
  • [49] EFFECT OF A GLP-1 RECEPTOR AGONIST AND SGLT-2 INHIBITOR COMBINATION ON BLOOD PRESSURE LEVELS COMPARED TO SGLT-2 INHIBITOR ALONE: A SYSTEMATIC REVIEW AND META-ANALYSIS
    Patoulias, Dimitrios
    Imprialos, Konstantinos
    Stavropoulos, Konstantinos
    Katsimardou, Alexandra
    Kalogirou, Maria
    Manafis, Alexandros
    Lales, Georgios
    Sampanis, Christos
    Zografou, Ioanna
    Karagiannis, Asterios
    Doumas, Michael
    JOURNAL OF HYPERTENSION, 2021, 39 : E212 - E212
  • [50] An SGLT-2 inhibitor reverses impaired ventricular repolarisation in patients with type 2 diabetes
    Sato, T.
    Miki, T.
    Ohnishi, H.
    Yamashita, T.
    Takada, A.
    Yano, T.
    Tanno, M.
    Tsuchida, A.
    Miura, T.
    DIABETOLOGIA, 2017, 60 : S424 - S425
12345